Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (401-410 of 567) with videos related to

Pageof 57
Sort By:
Circulation|May 1, 1993
Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study GroupJ K Harrison, R M Califf, L H Woodlief, et al.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Journal of the American College of Cardiology|March 15, 1997
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries InvestigatorsA Barbagelata, R M Califf, E B Sgarbossa, et al.
American Heart Journal|October 1, 1993
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial InfarctionE M Ohman, R H Christenson, R M Califf, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1995
The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument databaseC Maynard, H P Selker, J R Beshansky, et al.
Circulation|February 2, 2000
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromesD B Mark, R A Harrington, A M Lincoff, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|November 15, 2000
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupR H Christenson, R T Vollmer, E M Ohman, et al.
Pageof 57

Showing results (401-410 of 567) with videos related to

Sort By:
Pageof 57
Circulation|May 1, 1993
Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study GroupJ K Harrison, R M Califf, L H Woodlief, et al.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
Journal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.
Journal of the American College of Cardiology|March 15, 1997
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries InvestigatorsA Barbagelata, R M Califf, E B Sgarbossa, et al.
American Heart Journal|October 1, 1993
Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial InfarctionE M Ohman, R H Christenson, R M Califf, et al.
American Heart Journal|March 1, 1991
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study GroupE M Ohman, R M Califf, B S George, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1995
The exclusion of women from clinical trials of thrombolytic therapy: implications for developing the thrombolytic predictive instrument databaseC Maynard, H P Selker, J R Beshansky, et al.
Circulation|February 2, 2000
Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromesD B Mark, R A Harrington, A M Lincoff, et al.
The American Journal of Cardiology|November 15, 1995
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupA Barbagelata, C B Granger, E J Topol, et al.
The American Journal of Cardiology|November 15, 2000
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study GroupR H Christenson, R T Vollmer, E M Ohman, et al.
Pageof 57